MarketInOut Stock Screener Log In | Sign Up

Qiagen N.V.

XETRA • Healthcare • Diagnostics & Research • Quote as of 10/30/2026
Qiagen N.V. stock price and volume chart

Company Profile

IndustryDiagnostics & Research
SectorHealthcare
ExchangeXETRA
Market Capitalization9,302.67 mln
Float205 mln
Earnings Date11/04/2026

EPS

1.69
Moderate

P / E

26.68
Elevated

Piotroski F-Score

5 / 9
Neutral

Beneish M-Score

-2.64
Likely reliable

1-Year Forecast

43.10
Fairly priced

Relative Strength

97 / 100
Top performer

Business Description

Founded in 1984 and based in the Netherlands, Qiagen helps scientists and medical professionals around the world extract useful information from biological samples. The company sells a wide range of tools, kits, and instruments used to isolate and analyze genetic material, supporting work in disease detection, cancer research, prenatal testing, and forensics. Qiagen also provides software and data analysis services to help customers make sense of complex biological data.

Key Fundamentals

EPS1.69
P/E26.68
ROE11.61
RPS9.09
ROIC9.68
ROA6.75
Interest Cover13.12
EBITDA, mln603
EV / EBITDA15.98
EV / EBIT22.43
Revenue, mln1,801
EV / Revenue5.35

Quote Details

Last 45.09
Change 0.04 (0.09%)
Open 45.12
Volume 572,512
Turnover 25,814,566
Average Volume 1,295,789

Financial Ratios

Pre-Tax Profit Margin22
Leverage Ratio1.75
Current Ratio2.85
Price / Book3.09
Price / Tangible Book33.16
Price / Cash Flow15.87
Price / Free Cash Flow23.30
Debt / Equity0.49
Price / Sales4.97
PEG Ratio1.34

Financial Strength

Altman Z-Score3.98
Piotroski F-Score 5 / 9
Beneish M-Score-2.64
Price to Intrinsic Value1.49
Price to Graham Number5.77
1-Year Target Price43.10
Shiller PE Ratio35.38

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 0.09% 39 / 100   
1 Month 18.07% 97 / 100   
2 Months 22.89% 96 / 100   
6 Months 59.67% 99 / 100   
1 Year 11.64% 52 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog